Open Call for High-Impact Personalized Medicine Evidence

Call for Papers
International Journal of Personalized Medicine

Contribute clinically meaningful precision and personalized medicine research designed to improve real-world decisions across multidisciplinary care pathways.

45%APC Savings

ClinicalResearch Reach

FastEditorial Routing

Current Call

Priority Research Areas in Personalized Medicine

We invite clinically relevant manuscripts that improve diagnosis, treatment pathways, clinical outcomes, and long-term patient quality of life.

International Journal of Personalized Medicine welcomes rigorous submissions in pharmacogenomics, biomarker-guided therapy, multi-omics translation, precision diagnostics, AI-supported risk stratification, and adaptive treatment strategy design.

Priority is given to studies that combine methodological strength with practical implications for decision-making in clinics, multidisciplinary tumor boards, and precision-care pathways.

The journal values evidence that advances standards of care, strengthens risk stratification, and clarifies outcomes across diverse patient populations and healthcare settings.

Pharmacogenomics and Drug Response

Studies linking variants and pathways to dosing, efficacy, toxicity reduction, and individualized prescribing frameworks.

Biomarker-Guided Clinical Decisions

Evidence on diagnostic markers, response prediction, and treatment selection that improves outcome precision.

Multi-Omics Integration

Genomic, transcriptomic, proteomic, and metabolomic models that inform robust, clinically interpretable risk or response profiles.

AI and Predictive Modeling

Validated machine-learning models for patient stratification, prognosis, and decision support with transparent evaluation metrics.

Precision Oncology and Rare Disease

Targeted therapy strategy reports, molecular board workflows, and clinically actionable interpretation pipelines.

Translational Personalized Care

Implementation-focused studies connecting discovery-stage evidence with real-world personalized treatment pathways.

Quality Signals

What Strong Manuscripts Consistently Show

Editorial triage and review prioritize transparent methods, defensible interpretation, and clinical relevance.

Clearly defined study question with justified design and endpoint framework.
Transparent participant criteria, procedural details, and outcome measurement methods.
Appropriate statistical approach including sensitivity analysis where relevant.
Balanced interpretation that distinguishes robust findings from exploratory observations.
Complete ethics, consent, funding, and conflict of interest disclosures.
Accurate references and terminology consistency across all manuscript sections.

Authors are encouraged to describe implementation context, including service constraints and resource conditions, so readers can evaluate transferability of findings.

Multicenter submissions should clarify center-level variation handling and protocol harmonization strategy to strengthen reproducibility claims.

Accepted Formats

Manuscript Types Included in This Call

Multiple manuscript categories are accepted when evidence quality and reporting standards are met.

Original Clinical Research

Prospective or retrospective analyses with robust methodology and clinically interpretable outcomes.

Systematic Reviews and Meta-analyses

Protocol-based evidence synthesis with transparent search and selection logic.

Translational Reports

Mechanistic or biomarker studies linked to diagnostic or therapeutic decision value.

Practice and Implementation Studies

Operational research on pathway redesign, quality improvement, and access optimization.

Short Communications

Focused findings with immediate relevance and strong methodological framing.

Perspectives and Policy Commentary

Evidence-grounded expert viewpoints on evolving standards and strategic priorities.

Scope note: Manuscripts outside personalized medicine and closely related translational domains may be declined at triage.

Submission Methods

Two Routes, One Editorial Standard

Both submission options are supported by the same editorial team and quality framework.

Manuscriptzone Submission

Recommended for teams needing structured data fields, formal revision tracking, and institutional workflow compatibility.

Simple Submission Form

Suitable for rapid initial intake when authors require a streamlined process and direct communication.

Pre-submission Questions

Scope and formatting questions can be sent to [email protected] before submission to reduce avoidable delays.

After submission, manuscripts move through editorial screening, specialist reviewer assignment, and decision communication with actionable revision priorities.

High-quality studies that align with these priorities are positioned for global open access visibility through the journals indexing ecosystem.

High-impact manuscripts typically explain how findings alter diagnosis, treatment selection, or patient pathway planning in real practice.

Authors should state endpoint hierarchy clearly so reviewers can assess interpretive strength without ambiguity.

Submissions addressing underserved populations and implementation barriers are strongly encouraged.

Structured reporting improves review efficiency and reduces avoidable revision cycles.

Collaborative multicenter studies are welcome when data governance and method consistency are clearly documented.